Faculty Opinions recommendation of Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

2020 ◽  
Author(s):  
David Liebeskind
Keyword(s):  
Randomised Controlled Trial ◽  
Ischaemic Stroke ◽  
Acute Ischaemic Stroke ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Randomised Controlled

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

The Lancet ◽  
2020 ◽  
Vol 395 (10227) ◽  
pp. 878-887 ◽  
Author(s):  
Michael D Hill ◽  
Mayank Goyal ◽  
Bijoy K Menon ◽  
Raul G Nogueira ◽  
Ryan A McTaggart ◽  
...  
Keyword(s):  
Randomised Controlled Trial ◽  
Ischaemic Stroke ◽  
Acute Ischaemic Stroke ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Randomised Controlled

scholarly journals Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial

2019 ◽  
Vol 18 (4) ◽  
pp. 338-347 ◽  
Author(s):  
Andrei V Alexandrov ◽  
Martin Köhrmann ◽  
Lauri Soinne ◽  
Georgios Tsivgoulis ◽  
Andrew D Barreto ◽  
...  
Keyword(s):  
Randomised Controlled Trial ◽  
Ischaemic Stroke ◽  
Acute Ischaemic Stroke ◽  
Controlled Trial ◽  
Phase 3 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Randomised Controlled

scholarly journals Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial

2019 ◽  
Vol 7 (11) ◽  
pp. 834-844 ◽  
Author(s):  
Ildiko Lingvay ◽  
Andrei-Mircea Catarig ◽  
Juan P Frias ◽  
Harish Kumar ◽  
Nanna L Lausvig ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomised Controlled Trial ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Randomised Controlled
Sign in / Sign up

Export Citation Format

Share Document